VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,951,905 | +691.5% | 295,500 | +785.7% | 0.18% | +660.9% |
| Q2 2023 | $1,004,620 | -16.9% | 33,365 | -20.9% | 0.02% | +35.3% |
| Q4 2022 | $1,209,280 | +150.9% | 42,194 | +111.0% | 0.02% | +88.9% |
| Q3 2022 | $482,000 | -61.8% | 20,000 | -56.6% | 0.01% | -70.0% |
| Q2 2022 | $1,261,000 | -70.1% | 46,070 | -58.1% | 0.03% | -63.0% |
| Q1 2022 | $4,220,000 | -69.5% | 110,000 | -74.6% | 0.08% | -71.7% |
| Q4 2021 | $13,850,000 | +1007.1% | 432,434 | +917.5% | 0.29% | +266.7% |
| Q3 2021 | $1,251,000 | -91.7% | 42,500 | -90.4% | 0.08% | -78.2% |
| Q2 2021 | $15,122,000 | -43.6% | 445,000 | -46.1% | 0.36% | -65.1% |
| Q1 2021 | $26,812,000 | -16.8% | 825,000 | -7.8% | 1.02% | -18.7% |
| Q4 2020 | $32,238,000 | +458.6% | 894,997 | +258.0% | 1.26% | +386.1% |
| Q1 2020 | $5,771,000 | -53.1% | 250,000 | -45.7% | 0.26% | -65.6% |
| Q3 2019 | $12,299,000 | -39.9% | 460,478 | -42.4% | 0.75% | -38.3% |
| Q2 2019 | $20,448,000 | -37.7% | 800,000 | -45.3% | 1.22% | -44.7% |
| Q1 2019 | $32,819,000 | +22.3% | 1,463,800 | +15.1% | 2.21% | +4.1% |
| Q4 2018 | $26,826,000 | +9.3% | 1,271,900 | -4.0% | 2.12% | 0.0% |
| Q3 2018 | $24,536,000 | – | 1,324,861 | – | 2.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |